Kuancan Liu

8PUBLICATIONS
17CO-AUTHORS
ChemotherapyPredictive and prognostic markersMolecular targetsCancer diagnosisMedical molecular engineering of nucleic acids and proteins
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Oct 17, 2025
Chelerythrine inhibits esophageal squamous cell carcinoma progression via PINK1-Parkin-mediated mitophagy.

Yijian Zhou, Zhuo Wang, Hongzhou Zhao

|Oct 09, 2024
Epigenetic regulation of p63 blocks squamous-to-neuroendocrine transdifferentiation in esophageal development and malignancy.

Yongchun Zhang, Dimitris Karagiannis, Helu Liu

|Oct 27, 2023
Targeting the SOX2/CDP protein complex with a peptide suppresses the malignant progression of esophageal squamous cell carcinoma.

Yunyun Chen, Kun Zhang, Rui Zhang

|Oct 04, 2023
HPV16 infection promotes the malignant transformation of the esophagus and progression of esophageal squamous cell carcinoma.

Hongzhou Zhao, Yuxuan Wei, Jiaying Zhang

|Sep 22, 2022
SOX2 inhibits LLGL2 polarity protein in esophageal squamous cell carcinoma via miRNA-142-3p.

Shihui Zhang, Yunyun Chen, Qiong Hu

|Sep 07, 2021
The Wnt signaling pathway in tumorigenesis, pharmacological targets, and drug development for cancer therapy.

Zhuo Wang, Tingting Zhao, Shihui Zhang

Pageof 2

Frequent Collaborators

1 joint publications

Songlin Shi

1 joint publications

Yongchun Zhang

1 joint publications

Dimitris Karagiannis

1 joint publications

Helu Liu